AAIC 2025 Abstract
Mass Spectrometry Analysis of Vitreous Humor Reveals Novel Insights in Early and Late Onset Alzheimer's Disease
Study in peopleBiomarkers
Abstract
Background: More than 6 million Americans were living with Alzheimer's Disease (AD) in 2024, and that number is expected to triple over the next 40years. Although effective treatments for AD are becoming available, these are likely to be most effective when given early in the course of the disease.
